Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
Active, not recruiting · NCT04551170 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A | Active, not recruiting | Phase 2 | 2026-04-29 | NCT04551170 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | United States | 71 |